These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 21620611)

  • 21. Outcomes of interventions for recurrent disease after endoluminal intervention for superficial femoral artery disease.
    Davies MG; Bismuth J; Saad WE; Naoum JJ; Peden EK; Lumsden AB
    J Vasc Surg; 2010 Aug; 52(2):331-9.e1-2. PubMed ID: 20478687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
    de Grijs D; Teixeira P; Katz S
    J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses.
    Iida O; Uematsu M; Soga Y; Hirano K; Suzuki K; Yokoi H; Muramatsu T; Inoue N; Nanto S; Nagata S
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):611-7. PubMed ID: 21805562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-center experience in endovascular treatment for infrainguinal bypass obstructions.
    Baumann F; Engelberger RP; Makaloski V; Do DD; Baumgartner I; Diehm N
    J Vasc Interv Radiol; 2012 Aug; 23(8):1055-62. PubMed ID: 22840804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iliac Artery Stenting Combined with Ipsilateral Open Femoro-Popliteal Revascularization and Its Effect on Bypass Patency.
    Piazza M; Squizzato F; Lepidi S; Menegolo M; Grego F; Antonello M
    Ann Vasc Surg; 2017 Oct; 44():282-288. PubMed ID: 28479462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated femoral endarterectomy: impact of SFA TASC classification on recurrence of symptoms and need for additional intervention.
    Al-Khoury G; Marone L; Chaer R; Rhee R; Cho J; Leers S; Makaroun M; Gupta N
    J Vasc Surg; 2009 Oct; 50(4):784-9. PubMed ID: 19628359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
    Schneider JR; Verta MJ; Alonzo MJ; Hahn D; Patel NH; Kim S
    Vasc Endovascular Surg; 2011 Jul; 45(5):391-7. PubMed ID: 21669863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes and implications of failed infrainguinal endovascular stents.
    Gur I; Lee W; Akopian G; Rowe VL; Weaver FA; Katz SG
    J Vasc Surg; 2011 Mar; 53(3):658-66; discussion 667. PubMed ID: 21257284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender-related outcomes in the endovascular treatment of infrainguinal arterial obstructive disease.
    Pulli R; Dorigo W; Pratesi G; Fargion A; Angiletta D; Pratesi C
    J Vasc Surg; 2012 Jan; 55(1):105-12. PubMed ID: 21944917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryoplasty as endovascular treatment in the femoropopliteal region: hemodynamic results and follow-up at one year.
    Gonzalo B; Solanich T; Bellmunt S; Herranz C; González E; Arnedo G; Muñoz G; Florit S; Hospedales J; Lloret MD; Vallespín J; Giménez A
    Ann Vasc Surg; 2010 Jul; 24(5):680-5. PubMed ID: 20409679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
    Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
    Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
    Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.
    Schmieder GC; Richardson AI; Scott EC; Stokes GK; Meier GH; Panneton JM
    J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency.
    Lin Y; Tang X; Fu W; Kovach R; George JC; Guo D
    J Endovasc Ther; 2015 Jun; 22(3):319-26. PubMed ID: 25862365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
    Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG
    Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.
    Bertges DJ; White R; Cheng YC; Sun T; Ramkumar N; Goodney PP; Wilgus RW; Lottes AE; Smale JA; Drozda J; Raska M; Heise T; Jones WS; Tcheng JE; Eldrup-Jorgensen J; Sedrakyan A; Malone ML; Marinac-Dabic D; Thatcher R; Morales P; Krucoff MW; Cronenwett JL;
    J Vasc Surg; 2021 May; 73(5):1702-1714.e11. PubMed ID: 33080324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endovascular interventions for TASC II D femoropopliteal lesions.
    Baril DT; Chaer RA; Rhee RY; Makaroun MS; Marone LK
    J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.